v3.26.1
HISTORY, BUSINESS PURPOSE, LIQUIDITY AND GOING CONCERN (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]        
Accumulated deficit   $ 15,430,022 $ 17,858,617 $ 15,430,022
Liabilities   $ 1,477,556 2,323,652 1,477,556
Gross proceeds     398,000 503,088
Number of shares issued, value     398,000 503,088
Payment for settlement     150,000
Stock issued to vendor       $ 125,000
Common Stock [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Shares sold to investors, shares     232,444 290,262
sale of shares, per shares   $ 2.25 $ 2.25 $ 2.25
Gross proceeds     $ 523,000 $ 503,088
Number of shares issued 75,000   176,889 223,595
Gross proceeds       $ 628,088
Number of shares issued, value     $ 18 22
Payment for settlement $ 150,000     $ 7
Stock issued to vendor, shares       55,555
Stock issued to vendor       $ 6
Sanovas Ophthalmology LLC [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Other liabilities     $ 675,000  
Number of shares issued   296,000 125,000 150,000
Number of shares issued, value   $ 666,000    
Vendor [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Number of shares issued   75,000    
Payment for settlement   $ 150,000    
Stock issued to vendor, shares   55,555    
Stock issued to vendor   $ 125,000